Standout Papers

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer 1995 2026 2005 2015 4.2k
  1. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer (2005)
    Frances A. Shepherd, José Rodrigues Pereira et al. New England Journal of Medicine
  2. K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer (2008)
    Christos S. Karapetis, Shirin Khambata‐Ford et al. New England Journal of Medicine
  3. Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer (2003)
    Christine Ribic, Daniel J. Sargent et al. New England Journal of Medicine
  4. Cetuximab for the Treatment of Colorectal Cancer (2007)
    Derek J. Jonker, Chris J. O’Callaghan et al. New England Journal of Medicine
  5. The Jackknife and Bootstrap (1995)
    Jun Shao, Dongsheng Tu Springer series in statistics
  6. Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 (2005)
    Paul E. Goss, James N. Ingle et al. JNCI Journal of the National Cancer Institute
  7. Morphine, Gabapentin, or Their Combination for Neuropathic Pain (2005)
    Ian Gilron, Joan M. Bailey et al. New England Journal of Medicine
  8. Exemestane for Breast-Cancer Prevention in Postmenopausal Women (2011)
    Paul E. Goss, James N. Ingle et al. New England Journal of Medicine
  9. Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab (2010)
    Wendy De Roock, Derek J. Jonker et al. JAMA
  10. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years (2016)
    Paul E. Goss, James N. Ingle et al. New England Journal of Medicine
  11. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial (2021)
    Tingyan Shi, Jianqing Zhu et al. The Lancet Oncology
  12. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer (2024)
    Marie Plante, Janice S. Kwon et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 9 from Science/Nature 125 standout
Sub-graph 1 of 16

Citing Papers

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
Breast Cancer Treatment
2019 Standout
38 intermediate papers

Works of Dongsheng Tu being referenced

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
2016 Standout
Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
2013
and 29 more

Author Peers

Author Last Decade Papers Cites
Dongsheng Tu 15262 5814 8491 305 24.8k
Eric J. Feuer 17469 4803 10711 249 39.2k
Richard L. Schilsky 13490 5210 5835 377 22.6k
Richard Pazdur 19104 4972 9902 582 36.2k
Marc Buyse 14952 6019 7587 398 28.0k
Steven Piantadosi 10993 3136 10016 259 30.0k
Elizabeth A. Eisenhauer 15013 7149 12565 205 41.1k
Richard Simon 8578 5211 6492 347 35.0k
Kenneth R. Hess 15103 8322 14542 506 40.9k
Malcolm C. Pike 10196 4760 4110 402 32.6k
Louis Fehrenbacher 24845 7832 10026 156 35.2k

All Works

Loading papers...

Rankless by CCL
2026